Electrocardiogram Monitoring in Anesthetized Veterinary Patients: Arrhythmia Recognition

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Continuous electrocardiogram (ECG) monitoring is essential for assessing heart rate, rhythm, myocardial electrical stability, electrolyte balance, and autonomic tone in anesthetized veterinary patients, as recommended by AAHA guidelines, because arrhythmias can arise abruptly from anesthetic drugs, surgical stimulation, hypoxia, hypercapnia, or electrolyte shifts.
• Artifacts mimicking arrhythmias are common and must be distinguished from true dysrhythmias by assessing lead placement consistency, comparing ECG rate to pulse rate, evaluating R-R interval regularity, and confirming the presence of a palpable pulse, especially when cautery, patient movement, or electrode displacement occurs.
• Physiologic derangements such as hyperkalemia (manifesting as peaked T waves, prolonged PR, widened QRS, and loss of P waves) and hypokalemia/hypocalcemia (prolonging QT interval) significantly impact myocardial excitability and conduction, requiring prompt identification and correction of the underlying cause rather than solely antiarrhythmic therapy.
• Anesthetic drug classes exert distinct effects on cardiac rhythm: alpha-2 agonists increase vagal tone leading to bradycardia and AV block, while inhalation agents can sensitize the myocardium to catecholamines, and opioids increase vagal tone, necessitating careful consideration of drug combinations and anesthetic depth.
• Management of anesthetic arrhythmias prioritizes assessing hemodynamic impact (pulse deficits, hypotension), identifying and correcting reversible triggers (anesthetic depth, oxygenation, ventilation, perfusion, electrolytes), and then selecting appropriate antiarrhythmic therapy based on the specific arrhythmia and species, with lidocaine being a common choice for ventricular arrhythmias in dogs.
• Documentation of ECG findings, including rhythm diagnosis, heart rate, blood pressure, and interventions, is critical throughout anesthesia and recovery, and referral to a cardiologist is warranted for persistent or complex arrhythmias suggesting underlying structural heart disease.

Continuous electrocardiogram (ECG) monitoring is a standard component of anesthetic management in small animal practice, yet its value depends entirely on the clinician's ability to interpret what the trace displays. This article provides a structured approach to recognizing arrhythmias that arise during anesthesia in dogs and cats, distinguishing true dysrhythmias from monitoring artifacts, and initiating appropriate immediate management. The content serves practicing veterinarians who need a practical framework for ECG interpretation in the peri-anesthetic period, with emphasis on the arrhythmias most frequently encountered under anesthesia and the physiologic mechanisms that produce them. Long-term cardiology, including chronic antiarrhythmic therapy and advanced diagnostic imaging, lies outside the scope of this reference.

The ECG during anesthesia serves two distinct purposes. First, it provides continuous heart rate and rhythm assessment that complements pulse palpation and Doppler or oscillometric blood pressure measurement. Second, it offers a real-time window into myocardial electrical stability, electrolyte disturbances, and autonomic balance. The AAHA Anesthesia and Monitoring Guidelines for Dogs and Cats recommend ECG monitoring for all anesthetized patients, regardless of procedure duration or perceived cardiovascular risk. This recommendation reflects the reality that arrhythmias can develop abruptly in patients with no known cardiac disease, triggered by anesthetic drugs, surgical stimulation, hypoxia, hypercapnia, or electrolyte shifts.

At a Glance

Physiologic Basis of Anesthetic Arrhythmias

Autonomic Balance and Myocardial Excitability

The heart's electrical activity reflects a dynamic equilibrium between sympathetic and parasympathetic input. Anesthesia disrupts this balance through multiple mechanisms. Alpha-2 agonists such as dexmedetomidine increase vagal tone and decrease sympathetic outflow, producing bradycardia and enhancing the likelihood of atrioventricular block. Anticholinergics used to counteract this bradycardia can create a hyperdynamic state with accelerated junctional or ventricular rhythms. The interplay between these drug classes explains why heart rate changes often occur in phases during a single anesthetic episode.

Cardiac sympathetic and parasympathetic discharge does not remain constant during physiologic stress. Experimental work in cats has demonstrated that autonomic cardiac neural discharge becomes imbalanced during seizure activity, with simultaneous increases in both sympathetic and parasympathetic outflow instead of reciprocal changes. This imbalance can precipitate arrhythmias even in structurally normal hearts. The cardiac neural discharge and epileptogenic activity model illustrates that autonomic disruption alone can generate significant dysrhythmias, a principle that extends to the stresses of anesthesia and surgery.

Species Differences in Myocardial Response

Dogs and cats differ in their metabolic and electrophysiologic responses to increased cardiac workload. Comparative studies using phosphorus nuclear magnetic resonance have shown that dog hearts maintain high-energy phosphate homeostasis better than cat hearts when subjected to rapid pacing. The cardiac transfer function relating energy metabolism to workload demonstrated that cats develop greater changes in the inorganic phosphate to phosphocreatine ratio at equivalent heart rate-blood pressure products. This metabolic fragility may contribute to the cat's propensity for bradyarrhythmias and the relatively narrow margin between acceptable and dangerous heart rates during anesthesia.

Anesthetic drug selection also influences myocardial performance in species-specific ways. In rodent models, injectable combinations that include medetomidine produce more pronounced depression of cardiac function than inhalation anesthesia, with higher variability in measured ejection fraction. The role of 1.5 tesla MRI and anesthetic regimen concerning cardiac analysis showed that isoflurane at higher concentrations provided more stable hemodynamic conditions than a medetomidine-midazolam-fentanyl protocol. While direct extrapolation from mice to clinical patients requires caution, the principle that alpha-2 agonist-based protocols carry greater cardiovascular depression risk than inhalation anesthesia alone is well established in small animal practice.

Electrolyte Disturbances and Arrhythmogenesis

Hyperkalemia

Potassium concentration directly affects myocardial resting membrane potential. Hyperkalemia reduces the resting potential toward threshold, initially increasing excitability, then progressively impairing conduction as the gradient across the cell membrane narrows. The ECG changes follow a predictable sequence: peaking T waves, prolongation of the PR interval, widening of the QRS complex, loss of P waves, and ultimately a sine wave pattern preceding ventricular standstill. These changes are dose-dependent and reversible with appropriate treatment.

Hyperkalemia during anesthesia most commonly arises from iatrogenic causes, urinary obstruction, reperfusion injury, or metabolic acidosis. A reported case of hyperkalemia secondary to iatrogenic dextrose overdose in a diabetic dog demonstrates how a medication error can produce life-threatening electrolyte derangement. The dog received a tenfold overdose of 50% dextrose, resulting in blood glucose exceeding 41.7 mmol/L and subsequent hyperkalemia of 6.8 mmol/L. The ECG showed sinus rhythm with atrial bigeminy, which resolved as potassium normalized. This case underscores two lessons: the ECG can reveal electrolyte disturbances before laboratory results return, and medication errors in anesthesia require systematic review to prevent recurrence.

Hypokalemia and Hypocalcemia

Hypokalemia increases myocardial automaticity and can provoke atrial or ventricular premature complexes, particularly in patients receiving digoxin or with underlying myocardial disease. Hypocalcemia prolongs the QT interval and can predispose to ventricular arrhythmias, while hypercalcemia shortens the QT interval and may produce bradyarrhythmias. During anesthesia, these disturbances typically arise from pre-existing endocrine disease, diuretic therapy, or massive transfusion with citrate-preserved blood products. The ECG provides earlier warning of these abnormalities than clinical signs alone.

Anesthetic Drug Effects on Cardiac Rhythm

Inhalation Anesthetics

Halogenated inhalation agents prolong ventricular repolarization and can sensitize the myocardium to catecholamines. Halothane, now rarely used in small animal practice, carried the highest risk of ventricular arrhythmias, particularly when combined with epinephrine or hypercapnia. Isoflurane and sevoflurane have more favorable profiles but can still produce bradyarrhythmias, particularly at high vaporizer settings or in patients with pre-existing conduction disease. The vagolytic effect of atropine or glycopyrrolate may be needed to maintain adequate heart rate when inhalation anesthesia produces profound bradycardia.

Injectable Agents

Ketamine increases sympathetic outflow and heart rate, which can be desirable in hemodynamically unstable patients but problematic in those with hypertrophic cardiomyopathy or uncontrolled hypertension. The feline cardiac function index study using electro-acupuncture documented that ketamine-xylazine anesthesia caused transient hypertension in healthy cats, with the blood pressure elevation inhibited by electro-acupuncture at the PC6 acupoint. This finding illustrates that ketamine-based protocols produce measurable cardiovascular effects even in healthy subjects, and that adjunctive techniques may modulate these responses.

Propofol causes minimal direct arrhythmogenesis but can produce dose-dependent hypotension and reflex tachycardia. Opioids, particularly fentanyl and its derivatives, increase vagal tone and commonly produce bradycardia. The combination of multiple drugs with opposing autonomic effects can create windows of electrical instability, particularly during induction and at the transition to maintenance anesthesia.

Lead Placement and Signal Acquisition

Accurate arrhythmia recognition begins with a reliable signal. The ECG in the anesthetized patient serves three functions: heart rate display, rhythm diagnosis, and detection of perfusion-compromising events. A poor signal produces artifact that mimics arrhythmias, and the resulting misdiagnosis can trigger unnecessary treatment or mask a genuine emergency.

Electrode Positioning

Standard bipolar limb leads are sufficient for rhythm monitoring in most anesthetized dogs and cats. Place the right forelimb electrode at the elbow or carpus, the left forelimb electrode at the contralateral elbow or carpus, and the left hindlimb electrode at the stifle or tarsus. The right hindlimb electrode serves as the reference lead and should be placed regardless of whether a three-lead or five-lead system is used.

For surgical procedures involving the limbs, move electrodes proximally onto the trunk. Clip hair closely and use conductive gel or alcohol to ensure skin contact. Self-adhesive electrodes designed for human use adhere poorly to furred skin, alligator clip electrodes with gel remain the most reliable choice in veterinary patients.

A five-lead system adds precordial chest leads that improve detection of ventricular ectopy and bundle branch morphology. The precordial electrode placed at the right sixth intercostal space near the costochondral junction approximates the human V1 position and provides a consistent ventricular signal. In cats, the chest wall is thin and the electrode may need repositioning to avoid respiratory artifact.

Artifact Recognition

Artifact is the most common cause of apparent arrhythmias during anesthesia. Distinguish artifact from true arrhythmia by examining the relationship between the abnormal deflection and the preceding T wave, the regularity of the underlying rhythm, and the presence of a pulse. An audible Doppler pulse that remains regular while the ECG shows erratic deflections indicates artifact.

Common sources include:

• Cautery interference: high-frequency oscillation that obscures the baseline, typically resolves when cautery stops
• Respiratory variation: baseline wander synchronized with the breathing cycle, more pronounced in cats and brachycephalic dogs
• Patient movement: shivering, twitching, or surgical manipulation produces deflections that do not follow a P-QRS-T sequence
• Electrode displacement: sudden loss of signal or a flat line with no P waves, often from a loose clip
• Mechanical vibration: surgical drills, saws, or suction devices create regular high-frequency artifact

When artifact is suspected, check the electrode connections, confirm the pulse rate matches the ECG rate, and observe the tracing for several seconds before intervening. The AAHA anesthesia and monitoring guidelines recommend continuous ECG monitoring with simultaneous pulse assessment to differentiate true dysrhythmias from artifact.

Systematic ECG Interpretation

Interpret the ECG in a fixed sequence to avoid missing abnormalities. For each tracing, evaluate:

1. Heart rate and rhythm regularity
2. Presence and morphology of P waves
3. Relationship of P waves to QRS complexes
4. QRS duration and amplitude
5. ST segment and T wave morphology
6. Presence of ectopic complexes and their origin

Calculate the heart rate from the R-R interval. In dogs, normal sinus rhythm ranges from 60 to 180 beats per minute depending on size and breed, cats range from 120 to 240 beats per minute. Anesthetized patients often run at the lower end of these ranges due to vagal tone and anesthetic depth.

Sinus Rhythms

Sinus arrhythmia with phasic variation is normal in dogs and reflects respiratory sinus arrhythmia. Under anesthesia, this variation may diminish or disappear. Sinus bradycardia is common with opioid premedication and deep inhalant anesthesia. Sinus tachycardia occurs with inadequate anesthetic depth, hypovolemia, hypercapnia, or anticholinergic administration.

Atrial Arrhythmias

Atrial premature complexes appear as early P waves with a different morphology from sinus P waves, followed by a QRS that is usually normal. They are often benign in anesthetized patients but may precede atrial fibrillation, particularly in dogs with underlying atrial enlargement.

Atrial fibrillation produces an irregularly irregular rhythm with no discernible P waves and fine baseline undulation. It occurs most commonly in large-breed dogs with dilated cardiomyopathy or chronic mitral valve disease. In cats, atrial fibrillation is rare and usually indicates severe atrial enlargement. The ventricular response rate depends on AV nodal conduction and anesthetic drug effects.

Ventricular Arrhythmias

Ventricular premature complexes (VPCs) appear as wide, bizarre QRS complexes not preceded by a P wave. The T wave is typically opposite in polarity to the QRS. VPCs during anesthesia require assessment of frequency, timing, and hemodynamic effect.

The table below provides a quick-reference framework for common anesthetic arrhythmias.

Arrhythmia Triggers During Anesthesia

Electrolyte and Metabolic Disturbances

Hyperkalemia produces characteriztic ECG changes that progress with severity: peaked T waves, prolonged PR interval, widened QRS, diminished P wave amplitude, and eventually sine wave morphology and ventricular standstill. The progression is dose-dependent and may be accelerated by acidosis.

A reported case of iatrogenic dextrose overdose in a diabetic dog under anesthesia illustrates this sequence. The dog developed hyperkalemia of 6.8 mmol/L with atrial bigeminy confirmed on ECG, which normalized as potassium levels improved. The case demonstrates that ECG changes may be the first indication of a serious metabolic disturbance, and that rhythm abnormalities can resolve with correction of the underlying cause instead of antiarrhythmic therapy. See the case report on hyperkalemia secondary to dextrose overdose for details.

Hypokalemia and hypocalcemia prolong the QT interval and predispose to ventricular arrhythmias, though these changes are less specific than the hyperkalemic pattern.

Anesthetic Drug Effects

Inhalation anesthetics sensitize the myocardium to catecholamines, increasing the risk of ventricular arrhythmias, particularly with halothane. Isoflurane and sevoflurane are less arrhythmogenic but still depress myocardial contractility in a dose-dependent manner. The AAHA anesthesia and monitoring guidelines emphasize that anesthetic depth and drug selection should be tailored to the individual patient's cardiovascular status.

Ketamine increases sympathetic outflow and heart rate, which may be beneficial in hypotensive patients but can precipitate tachyarrhythmias in those with pre-existing cardiac disease. Alpha-2 agonists such as dexmedetomidine cause bradycardia and AV block through central sympatholysis and increased vagal tone.

Surgical Stimulation and Reflexes

Ocular surgery, particularly traction on the extraocular muscles, can trigger the oculocardiac reflex with profound bradycardia or AV block. Traction on abdominal viscera, the mesentery, or the larynx produces similar vagally mediated bradyarrhythmias. These reflexes are more pronounced in cats and in pediatric patients.

Management Decision Framework

The decision to treat an arrhythmia during anesthesia depends on three factors: hemodynamic impact, arrhythmia type, and underlying cause.

Step 1: Assess Perfusion

Check the Doppler pulse, mucous membrane color, capillary refill time, and arterial blood pressure. An arrhythmia that does not produce pulse deficits or hypotension may not require immediate antiarrhythmic therapy. The MSD Veterinary Manual notes that many anesthetic arrhythmias are transient and resolve with adjustment of anesthetic depth or correction of the inciting cause.

Step 2: Identify and Correct Triggers

Before administering antiarrhythmic drugs, address reversible causes:

• Lighten or deepen anesthesia as appropriate
• Correct hypoxemia, hypercapnia, or acidosis
• Replace volume deficits
• Correct electrolyte abnormalities
• Stop surgical stimulation triggering a vagal reflex
• Reduce catecholamine release by ensuring adequate analgesia

Step 3: Select Specific Therapy

Antiarrhythmic drug selection depends on the arrhythmia and the patient's hemodynamic status. Lidocaine is the first-line agent for ventricular arrhythmias in dogs but is poorly effective and potentially toxic in cats. Beta-blockers are used for supraventricular tachyarrhythmias but may worsen hypotension. Atropine or glycopyrrolate treats vagally mediated bradyarrhythmias.

Consult a current formulary for doses and contraindications, as drug selection varies with species and clinical context.

Documentation and Monitoring

Record the ECG rhythm at regular intervals throughout anesthesia, typically every 5 minutes along with other vital parameters. Note the lead used, heart rate, rhythm diagnosis, and any treatment administered. When an arrhythmia is detected, document its onset, duration, hemodynamic effect, and response to intervention.

Continuous ECG monitoring should continue through recovery, as arrhythmias may emerge as anesthetic depth lightens and sympathetic tone increases. The WSAVA Global Pain Council guidelines emphasize that adequate analgesia reduces stress-related catecholamine release, which in turn reduces arrhythmia risk during recovery.

For patients with known cardiac disease or those undergoing procedures with high arrhythmia risk, consider continuous blood pressure monitoring alongside ECG. The combination of ECG and blood pressure provides a more complete picture of hemodynamic status than either parameter alone.

Recognized Complications and Failure Modes

The most consequential ECG monitoring failures during anesthesia are not arrhythmias themselves but the failure to detect them in time. Three failure modes account for most adverse outcomes.

First, the ECG is treated as a proxy for perfusion. The electrical signal confirms rhythm, not cardiac output. A patient can maintain a normal sinus rhythm while in profound hypotension, and can develop ventricular tachycardia with acceptable perfusion. The ECG must be interpreted alongside pulse quality, Doppler or oscillometric blood pressure, mucous membrane color, and capillary refill time. The AAHA anesthesia and monitoring guidelines for dogs and cats emphasize that no single monitor is sufficient and that multiple parameters must be assessed together.

Second, artifact is mistaken for arrhythmia, or arrhythmia is dismissed as artifact. Both errors are common. The discriminating question is whether the abnormal deflection repeats in every lead, whether it correlates with a palpable pulse, and whether it persists when the electrodes are repositioned or the patient is moved.

Third, the monitoring interval is too long. Arrhythmias that occur during surgical stimulation, anesthetic depth changes, or drug administration are often transient. A patient checked every five minutes may appear stable while a paroxysmal ventricular tachycardia goes unrecognized. Continuous audible ECG output, with the anesthetist trained to respond to rate and rhythm changes immediately, is the standard of care.

Common Errors and Corrective Actions

Less experienced clinicians frequently misclassify hyperkalemic changes. The progression from peaked T waves to widened QRS to loss of P waves is often read as sinus bradycardia or accelerated idioventricular rhythm. A case report of iatrogenic dextrose overdose in a diabetic dog under anesthesia documented hyperkalemia of 6.8 mmol/L presenting as sinus rhythm with atrial bigeminy, which normalized with correction of the potassium disturbance. The corrective action is to measure blood gases or electrolytes whenever the ECG shows progressive QRS widening, T wave peaking, or unexplained bradycardia, particularly in patients with diabetes, renal disease, or recent fluid therapy.

Another common error is treating the arrhythmia before treating the cause. Anesthetic drug effects, hypoxemia, hypercapnia, hypotension, and surgical stimulation are more common triggers than primary cardiac disease. The WSAVA Global Pain Council guidelines note that inadequate analgesia is a recognized contributor to autonomic instability during procedures. The corrective sequence is to verify oxygenation, ventilation, perfusion, and anesthetic depth before reaching for an antiarrhythmic drug.

A third error is the assumption that a single ECG lead is sufficient. A single lead can hide P waves, making atrial fibrillation or sinus arrest difficult to distinguish from junctional rhythms. Using a second lead, or adjusting the lead selector, clarifies the diagnosis.

Limitations of Current Evidence

The evidence base for anesthetic arrhythmia management in veterinary patients is largely extrapolated from human medicine and from experimental models. Species differences in myocardial response are documented but incompletely characterized. Studies using phosphorus NMR spectroscopy in dogs and cats showed that dog hearts are more resistant than cat hearts to changes in high-energy phosphate metabolism with increasing work load, suggesting that the two species respond differently to cardiac stress. Whether these metabolic differences translate into different arrhythmia thresholds during anesthesia is not established.

Anesthetic regimens themselves influence cardiac measurements. A study of mice with cardiomyopathy found that medetomidine, midazolam, and fentanyl anesthesia depressed cardiac function parameters and produced more variability than isoflurane inhalation anesthesia. Extrapolation of these findings to clinical patients is limited by species and by the experimental setting.

Expert opinion still differs on several points. The threshold for treating ventricular arrhythmias in anesthetized patients varies among anesthesiologists. Some treat any run of ventricular tachycardia exceeding a few complexes, others treat only when perfusion is compromised. The role of lidocaine versus amiodarone as first-line therapy in dogs remains debated. There is no consensus on whether routine ECG monitoring should be mandatory for all anesthetized patients or only for those with known cardiac disease, although the trend in specialty practice is toward universal monitoring.

Escalation and Referral

Most anesthetic arrhythmias resolve with correction of the underlying trigger. Escalation is warranted when the arrhythmia persists despite correction of oxygenation, ventilation, perfusion, electrolyte, and anesthetic depth abnormalities, or when it is associated with deteriorating perfusion.

Referral to a veterinary cardiologist is appropriate when the arrhythmia is suspected to reflect structural heart disease instead of a transient anesthetic effect. This includes atrial fibrillation in a dog with echocardiographic evidence of atrial enlargement, or ventricular arrhythmias in a patient with a known cardiomyopathy. The MSD Veterinary Manual provides species-specific guidance on the diagnosis and management of cardiac arrhythmias that can inform the decision to refer.

Laboratory involvement is indicated when electrolyte or acid-base disturbances are suspected. Point-of-care analyzers measuring potassium, ionized calcium, glucose, and blood gases should be used intraoperatively when the ECG suggests metabolic arrhythmogenesis. The case of iatrogenic dextrose overdose illustrates that even a routine procedure can produce life-threatening electrolyte shifts requiring immediate laboratory confirmation.

Regulatory reporting is rarely required for anesthetic arrhythmias. It becomes relevant when the arrhythmia results from a drug error, a device malfunction, or an adverse drug event. The AVMA practice resources provide guidance on reporting adverse events and on the documentation expected in the medical record. An incident report should be filed when a medication error occurs, as described in the dextrose overdose case, so that the team can review the event and prevent recurrence.

Frequently Asked Questions

How should I prioritize ECG monitoring when only a pulse oximeter or Doppler is available?

A Doppler or pulse oximeter detects perfusion and pulse presence but cannot identify the rhythm. If a single ECG lead becomes available, place it to maximize QRS amplitude, typically using a modified base-apex lead in dogs and cats. When full monitoring is unavailable, increase the frequency of direct auscultation and palpation of peripheral pulses, and document pulse quality at least every five minutes. The AAHA anesthesia and monitoring guidelines recommend continuous ECG for all anesthetized patients, but when resources are constrained, auscultation combined with pulse assessment provides a partial safety net. Recognize that atrial fibrillation and frequent premature complexes can be missed without a visible tracing.

What ECG findings should prompt immediate notification of the supervising clinician?

Notify immediately for ventricular tachycardia, multiform ventricular premature complexes, R-on-T phenomenon, third-degree atrioventricular block, asystole, or any rhythm accompanied by pulse deficits or hypotension. Atrial bigeminy with pulse deficits warrants prompt attention, as illustrated in a reported case of iatrogenic hyperkalemia in a diabetic dog where ECG confirmed the arrhythmia only after Doppler pulse deficits were noted (case report on dextrose overdose and hyperkalemia). Sinus bradycardia, first-degree block, and occasional supraventricular premature complexes can often be managed by adjusting anesthetic depth and addressing triggers, but document them and recheck the rhythm within five minutes.

How does arrhythmia management differ between cats and dogs during anesthesia?

Cats show greater myocardial sensitivity to catecholamines and develop ventricular arrhythmias at lower sympathetic stimulation than dogs. They also have higher resting heart rates, so bradycardia thresholds differ. Cats metabolize some anesthetics differently and may require longer washout before rhythm normalizes. In a feline model, ketamine and xylazine anesthesia produced transient hypertension that was attenuated by electro-acupuncture at PC6, suggesting that autonomic modulation can influence anesthetic cardiovascular effects in this species (acupuncture effects on feline cardiac function). Dogs more commonly present with pre-existing conduction disease or dilated cardiomyopathy. For both species, correct the underlying trigger before giving antiarrhythmic drugs, and use species-specific normal intervals when interpreting the ECG.

What documentation should be recorded for an intraoperative arrhythmia?

Record the time of onset, the specific rhythm diagnosis, heart rate, blood pressure, pulse quality, oxygen saturation, and end-tidal carbon dioxide at the time of detection. Note the current anesthetic depth, drug boluses given in the preceding 15 minutes, and any surgical manipulation occurring simultaneously. Document interventions, their timing, and the response. Include a printed or hand-drawn ECG strip in the record when possible. The MSD Veterinary Manual advises that monitoring records should allow a second clinician to reconstruct the event sequence. If the arrhythmia required treatment, record the drug, dose, route, and effect within five minutes of administration. This documentation supports both clinical continuity and medicolegal review.

How should I explain an intraoperative arrhythmia to a client after recovery?

Use plain language that describes what was observed without minimizing the event. State that the heart rhythm changed during anesthesia, that it was detected by continuous monitoring, and that it resolved or was treated. Explain that anesthetic drugs and surgical stimulation can temporarily alter heart rhythm and that most events do not indicate permanent heart disease. If the arrhythmia suggests underlying cardiac disease, recommend postoperative evaluation by a cardiologist. The AVMA practice resources emphasize clear communication of adverse events and their consequences. Avoid speculating about cause until the record is reviewed. Offer a written summary of the event and its management, and schedule a follow-up call within 24 hours.

When should I refer a patient for postoperative cardiac evaluation?

Refer when the arrhythmia was sustained, required antiarrhythmic therapy, or recurred after anesthetic recovery. Also refer if the patient has a pre-existing heart murmur, unexplained syncope, or exercise intolerance, or if the arrhythmia suggests structural disease such as ventricular tachycardia with multiform complexes. Patients with atrial fibrillation, high-grade atrioventricular block, or frequent ventricular premature complexes should have echocardiography and a 24-hour Holter monitor. The WSAVA pain council guidelines note that perioperative complications can unmask subclinical disease, and the same principle applies to arrhythmias. Referral is also appropriate when the practice lacks the equipment or expertise to characterize the rhythm fully.

Related Clinical & Scientific Guides

• Anesthetic Machine Leak Testing and Pressure Checks: A Step-by-Step Protocol
• Anesthetic Depth Assessment: Reflexes, Eye Position, and Ventilation
• Anesthesia for Patients with Obesity: Challenges and Solutions

References and Further Reading

• Acupuncture effects on cardiac functions measured by cardiac magnetic resonance imaging in a feline model.. 2010.
• Cardiac transfer function relating energy metabolism to workload in different species as studied with 31P NMR.. 1987.
• The role of 1.5 tesla MRI and anesthetic regimen concerning cardiac analysis in mice with cardiomyopathy.. 2014.
• Hyperkalemia secondary to iatrogenic overdose of intravenous dextrose supplementation in a diabetic dog undergoing anesthesia for phacoemulsification. 2025.
• Hyperkalemia secondary to iatrogenic overdose of intravenous dextrose supplementation in a diabetic dog undergoing anesthesia for phacoemulsification.. 2025.
• Cardiac neural discharge and epileptogenic activity in the cat: an animal model for unexplained death.. 1983.
• AAHA Anesthesia and Monitoring Guidelines for Dogs and Cats. AAHA.
• WSAVA Global Pain Council Guidelines. WSAVA.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.

Related Articles

• Local Anesthetic Systemic Toxicity in Veterinary Patients: Recognition and Treatment
• Temperature Management in Anesthetized Patients: Hypothermia and Hyperthermia
• Anesthesia for Patients with Cardiac Disease: Risk Assessment and Monitoring
• Anesthesia for Patients with Cancer: Paraneoplastic Syndromes
• Anesthesia for Patients with Sepsis: Hemodynamic Support

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.